Literature DB >> 25835506

Pathogenesis of polycystic ovary syndrome: multifactorial assessment from the foetal stage to menopause.

Anderson Sanches de Melo1, Sabrine Vilan Dias2, Ricardo de Carvalho Cavalli2, Viviane Cunha Cardoso2, Heloisa Bettiol2, Marco Antonio Barbieri2, Rui Alberto Ferriani2, Carolina Sales Vieira2.   

Abstract

Polycystic ovary syndrome (PCOS) is a multifactorial disorder that arises from interactions between genetic, environmental and intra-uterine factors. Small-for-gestational-age (SGA) babies and the daughters of mothers with PCOS represent possible postnatal clinical targets for developmental programming by steroid excess. The presence of excess glucocorticoids and/or androgens during foetal organogenesis and growth might promote changes in gene expression, and these changes might be related to an increase in the risk of PCOS-like reproductive and metabolic disorders in postnatal life, such as rapid growth and weight gain during the first 2 years of life (only in SGA babies), hyperinsulinaemia, adipocyte dysfunction and childhood visceral obesity, premature pubarche and adrenarche (only in SGA babies) and PCOS. In the fourth decade of life, women who have PCOS may be at higher risk for type 2 diabetes mellitus, dyslipidaemia and systemic arterial hypertension, which suggests that these women are also at higher risk for cardiovascular disease during menopause. However, PCOS can also occur in women who were born at appropriate weight for GA or in newborns of women without PCOS, which suggests that genetic variation and environmental factors play important roles in the development and maintenance of PCOS in a population. Genome-wide association studies based on adequate population samples have shown a higher frequency of genetic polymorphisms of the LHCGR, THADA and DENND1A genes in women with PCOS. Genetic studies of PCOS have also included analyses of structural changes in the chromosome based on an assessment of telomere length in single, cross-sectional evaluations, and these studies have produced controversial results. The present narrative review assesses the multifactorial origins of PCOS (including environmental, genetic and intra-uterine factors) and the development of conditions associated with this disorder. It is concluded that although PCOS might originate in the intra-uterine environment through developmental programming by steroid excess, the interaction between genetic and environmental factors is crucial for its appearance. Follow-up studies should be conducted to assess the same populations over their entire lifespans while taking into account different aspects of the pathogenesis of PCOS.
© 2015 Society for Reproduction and Fertility.

Entities:  

Mesh:

Year:  2015        PMID: 25835506     DOI: 10.1530/REP-14-0499

Source DB:  PubMed          Journal:  Reproduction        ISSN: 1470-1626            Impact factor:   3.906


  26 in total

Review 1.  Polycystic ovary syndrome throughout a woman's life.

Authors:  José Bellver; Luis Rodríguez-Tabernero; Ana Robles; Elkin Muñoz; Francisca Martínez; José Landeras; Juan García-Velasco; Juan Fontes; Mónica Álvarez; Claudio Álvarez; Belén Acevedo
Journal:  J Assist Reprod Genet       Date:  2017-09-27       Impact factor: 3.412

2.  Association of single nucleotide polymorphisms in the RAB5B gene 3'UTR region with polycystic ovary syndrome in Chinese Han women.

Authors:  Jia Yu; Caifei Ding; Siqi Guan; Chenye Wang
Journal:  Biosci Rep       Date:  2019-05-14       Impact factor: 3.840

3.  Glucocorticoid signaling and lipid metabolism disturbances in the liver of rats treated with 5α-dihydrotestosterone in an animal model of polycystic ovary syndrome.

Authors:  Danijela Vojnović Milutinović; Ana Teofilović; Nataša Veličković; Jelena Brkljačić; Sanja Jelača; Ana Djordjevic; Djuro Macut
Journal:  Endocrine       Date:  2021-01-15       Impact factor: 3.633

4.  Further delineation of familial polycystic ovary syndrome (PCOS) via whole-exome sequencing: PCOS-related rare FBN3 and FN1 gene variants are identified.

Authors:  Cengiz Karakaya; Aylin Pelin Çil; Kaya Bilguvar; Tunahan Çakir; Mete Hakan Karalok; Recep Onur Karabacak; Ahmet Okay Caglayan
Journal:  J Obstet Gynaecol Res       Date:  2022-02-09       Impact factor: 1.697

Review 5.  Effect of maternal PCOS and PCOS-like phenotype on the offspring's health.

Authors:  Muraly Puttabyatappa; Rodolfo C Cardoso; Vasantha Padmanabhan
Journal:  Mol Cell Endocrinol       Date:  2015-11-27       Impact factor: 4.102

Review 6.  The Role of Genetics, Epigenetics and Lifestyle in Polycystic Ovary Syndrome Development: the State of the Art.

Authors:  Vincenzina Bruni; Anna Capozzi; Stefano Lello
Journal:  Reprod Sci       Date:  2021-03-11       Impact factor: 3.060

Review 7.  Polycystic Ovary Syndrome and Periodontal disease: Underlying Links- A Review.

Authors:  Sri Chandana Tanguturi; Sreenivas Nagarakanti
Journal:  Indian J Endocrinol Metab       Date:  2018 Mar-Apr

8.  Polycystic Ovary Syndrome in adolescents: a qualitative study.

Authors:  Marzieh Saei Ghare Naz; Fahimeh Ramezani Tehrani; Giti Ozgoli
Journal:  Psychol Res Behav Manag       Date:  2019-08-22

9.  Polycystic Ovarian Syndrome and Menopause in Forty Plus Women.

Authors:  Sudhaa Sharma; Neha Mahajan
Journal:  J Midlife Health       Date:  2021-04-17

Review 10.  Hormonal contraception in women with polycystic ovary syndrome: choices, challenges, and noncontraceptive benefits.

Authors:  Anderson Sanches de Melo; Rosana Maria Dos Reis; Rui Alberto Ferriani; Carolina Sales Vieira
Journal:  Open Access J Contracept       Date:  2017-02-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.